1-3 of 3
E. Zamagni
Close
Sort by
Journal Articles

Gene Expression Profiling (GEP) of Myeloma (MM) Cells To Predict Attainment (near) Complete Response to Primary Therapy with Thalidomide-Dexamethasone (Thali-Dex) for Newly Diagnosed MM.

Carolina Terragna, M. Renzulli, D. Remondini, E. Tagliafico, E. Roncaglia, P. Tosi, E. Zamagni, P. Tacchetti, G. Perrone, M. Ceccolini, Giovanni Martinelli, M. Baccarani, M. Cavo
Journal: Blood
Blood (2006) 108 (11): 245.
https://doi.org/10.1182/blood.V108.11.245.245
Published: 2006
Journal Articles

CKS1B Over-Expression Significantly Predicts for a Lower Rate of Response to Primary Therapy with Thalidomide-Dexamethasone (Thali-Dex) for Newly Diagnosed Multiple Myeloma (MM) Patients.

Matteo Renzulli, C. Terragna, N. Testoni, E. Montanari, P. Tosi, E. Zamagni, P. Tacchetti, G. Perrone, Giovanni Martinelli, M. Baccarani, M. Cavo
Journal: Blood
Blood (2006) 108 (11): 371.
https://doi.org/10.1182/blood.V108.11.371.371
Published: 2006
Journal Articles

Insuline-Like Growth Factor 1 Is over Expressed in Multiple Myeloma Plasma Cells and Regulates the Expression of the Insuline-Like Growth Factor 1 Receptor.

C. Terragna, M. Renzulli, N. Testoni, T. Grafone, P. Tosi, E. Zamagni, C. Cellini, E. Ottaviani, S. Colarossi, I. Iacobucci, A. Poerio, G. Martinelli, M. Baccarani, M. Cavo
Journal: Blood
Blood (2005) 106 (11): 4363.
https://doi.org/10.1182/blood.V106.11.4363.4363
Published: 2005